DE69919868D1 - Oregano zur behandlung interner parasiten und protozoen - Google Patents

Oregano zur behandlung interner parasiten und protozoen

Info

Publication number
DE69919868D1
DE69919868D1 DE69919868T DE69919868T DE69919868D1 DE 69919868 D1 DE69919868 D1 DE 69919868D1 DE 69919868 T DE69919868 T DE 69919868T DE 69919868 T DE69919868 T DE 69919868T DE 69919868 D1 DE69919868 D1 DE 69919868D1
Authority
DE
Germany
Prior art keywords
oregano
protozoes
internal parasites
treating internal
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919868T
Other languages
English (en)
Other versions
DE69919868T2 (de
Inventor
L Deluca
S Sparks
A Ronzio
R Deluca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotics Research Corp
Original Assignee
Biotics Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotics Research Corp filed Critical Biotics Research Corp
Publication of DE69919868D1 publication Critical patent/DE69919868D1/de
Application granted granted Critical
Publication of DE69919868T2 publication Critical patent/DE69919868T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69919868T 1998-06-18 1999-06-16 Oregano zur behandlung interner parasiten und protozoen Expired - Lifetime DE69919868T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/099,580 US5955086A (en) 1998-06-18 1998-06-18 Oregano for the treatment of internal parasites and protozoa
US99580 1998-06-18
PCT/US1999/013497 WO1999065505A1 (en) 1998-06-18 1999-06-16 Oregano for the treatment of internal parasites and protozoa

Publications (2)

Publication Number Publication Date
DE69919868D1 true DE69919868D1 (de) 2004-10-07
DE69919868T2 DE69919868T2 (de) 2005-08-25

Family

ID=22275684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919868T Expired - Lifetime DE69919868T2 (de) 1998-06-18 1999-06-16 Oregano zur behandlung interner parasiten und protozoen

Country Status (10)

Country Link
US (1) US5955086A (de)
EP (1) EP1089745B1 (de)
JP (1) JP4558200B2 (de)
AT (1) ATE274915T1 (de)
AU (1) AU741087B2 (de)
CA (1) CA2335485C (de)
DE (1) DE69919868T2 (de)
ES (1) ES2228057T3 (de)
MX (1) MXPA00012685A (de)
WO (1) WO1999065505A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1881600A (en) * 1998-12-23 2000-07-31 Alza Corporation Dosage forms comprising porous particles
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6579542B1 (en) * 2000-03-02 2003-06-17 Cecil Faulkner Treating feline-specific disorders by orally administering Hydrastis canadensis
RU2279219C2 (ru) * 2001-01-23 2006-07-10 Ван Бик Глобал, ЛЛС. Пестицидные композиции и способ борьбы с паразитами
US6884763B2 (en) 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
BR0307667A (pt) * 2002-02-13 2006-04-11 Beek Global L L C Van composições e métodos para aumentar a produção de leite em animais
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
BRPI0418960B1 (pt) * 2004-07-21 2020-11-03 Alltech, Inc. composição formulada para administração oral para redução dos efeitos prejudiciais de uma infecção em um animal aviário causada por um organismo protozoário de uma espécie de eimeria
US8119169B2 (en) * 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
US20080032021A1 (en) * 2006-05-19 2008-02-07 Faltys Gary L Feed supplements for ruminants including essential oil compounds and organic acids
WO2009111685A1 (en) 2008-03-06 2009-09-11 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
WO2011029077A2 (en) * 2009-09-04 2011-03-10 Sensient Flavors Llc Botanical extracts and flavor systems and methods of making and using the same
US20130101634A1 (en) * 2011-10-12 2013-04-25 Deerland Enzymes, Inc. Compositions and methods for reducing microbial overgrowth in the small intestines
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
US9913478B2 (en) * 2013-12-02 2018-03-13 Arrowhead Center, Inc. Organic and environmentally “green” biocide compositions and applications
JP6372158B2 (ja) * 2014-05-15 2018-08-15 住友ベークライト株式会社 食品包装用シート、食品包装容器および食品包装体
GR20180100568A (el) * 2018-12-27 2020-07-16 Μαριανα Γεωργιου Χατζαρα Συνθεση με βαση το δικταμο κατα του βακτηριου ακανθαμοεμπα που προσβαλλει τους οφθαλμους

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1124855C (zh) * 1995-05-26 2003-10-22 罗帕法姆公司 牛至油制备治疗微生物引起动物胃肠道疾病的药物的用途
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.

Also Published As

Publication number Publication date
WO1999065505A1 (en) 1999-12-23
ES2228057T3 (es) 2005-04-01
AU4442099A (en) 2000-01-05
CA2335485C (en) 2008-12-02
ATE274915T1 (de) 2004-09-15
CA2335485A1 (en) 1999-12-23
AU741087B2 (en) 2001-11-22
DE69919868T2 (de) 2005-08-25
US5955086A (en) 1999-09-21
EP1089745A1 (de) 2001-04-11
JP4558200B2 (ja) 2010-10-06
EP1089745A4 (de) 2002-03-20
JP2002518338A (ja) 2002-06-25
EP1089745B1 (de) 2004-09-01
MXPA00012685A (es) 2003-09-10

Similar Documents

Publication Publication Date Title
DE69919868D1 (de) Oregano zur behandlung interner parasiten und protozoen
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
DE60117896D1 (de) Verfahrensschema zur Behandlung von Diesel und Vakuumgasöl
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
DE60120667D1 (de) Methoden und mittel zur behandlung von bandscheibenverschleiss
DE59902314D1 (de) Oligomerisiertes Organopolysiloxan-Cokondensat, dessen Herstellung und dessen Verwendung zur Behandlung von Oberflächen
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69913548D1 (de) Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE60231616D1 (de) Mittel zur verhinderung und behandlung von sexuell übertragenen krankheiten-i
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60219658D1 (de) Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60102812D1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE412423T1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition